Annual Report

Overview

The report presents NATCO Pharma's FY 2022-23 consolidated revenue of 28,117 million alongside total energy consumption of 553916GJ and water consumption of 301673KL. Renewable sources met 27.51% of total energy requirements. The report also details the company's environmental management, social initiatives and governance structure across dedicated ESG and BRSR sections.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2022-2023
Period: 1 April 2022 – 31 March 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services